Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Merck
Daiichi Sankyo
Accenture
Express Scripts
Healthtrust
Cantor Fitzgerald
Teva
Medtronic

Generated: June 23, 2018

DrugPatentWatch Database Preview

SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Skin Exposure Reduction Paste Against Chemical Warfare Agents, and what generic alternatives are available?

Skin Exposure Reduction Paste Against Chemical Warfare Agents is a drug marketed by Us Army and is included in one NDA.

The generic ingredient in SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS is perfluoropolymethylisopropyl ether; polytetrafluoroethylene. Additional details are available on the perfluoropolymethylisopropyl ether; polytetrafluoroethylene profile page.
Summary for SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS
Drug patent expirations by year for SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS

US Patents and Regulatory Information for SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Army SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS perfluoropolymethylisopropyl ether; polytetrafluoroethylene PASTE;TOPICAL 021084-001 Feb 17, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Army SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS perfluoropolymethylisopropyl ether; polytetrafluoroethylene PASTE;TOPICAL 021084-001 Feb 17, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health
Teva
Citi
Merck
Fuji
Accenture
McKesson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.